Anti-Human NTRK1 Monoclonal Antibody (1A717)
The Anti-Human NTRK1 Monoclonal Antibody (1A717) is a highly specific and potent tool for studying the biological function of NTRK1, also known as TrkA. This antibody is produced using advanced monoclonal antibody technology and has been extensively validated for use in a variety of applications.
NTRK1 is a receptor tyrosine kinase that plays a crucial role in cell growth, differentiation, and survival. It is a key regulator of the nervous system and is involved in various diseases, including cancer. This makes NTRK1 an important target for research and drug development.
The main applications of the Anti-Human NTRK1 Monoclonal Antibody (1A717) include Western blotting, immunohistochemistry, and flow cytometry. It has been shown to specifically recognize NTRK1 in human tissues and cell lines, making it a reliable tool for studying the expression and localization of this protein.
In addition to its use in basic research, this antibody has also been used in experimental studies to investigate the role of NTRK1 in various diseases. For example, it has been used to study the role of NTRK1 in breast cancer and its potential as a therapeutic target.
With its high specificity and sensitivity, the Anti-Human NTRK1 Monoclonal Antibody (1A717) is a valuable tool for researchers studying NTRK1 and its role in various biological processes and diseases. Its use in multiple applications and experimental studies highlights its versatility and reliability.
In summary, the Anti-Human NTRK1 Monoclonal Antibody (1A717) is a powerful tool for studying the function of NTRK1 and its potential as a therapeutic target in various diseases. Its specificity, sensitivity, and versatility make it a top choice for researchers in the biotech field. Order now and advance your research with this highly effective antibody.
There are no reviews yet.